Correlation Between Health Biotchnology and Cullen Emerging

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Health Biotchnology and Cullen Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Biotchnology and Cullen Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Biotchnology Portfolio and Cullen Emerging Markets, you can compare the effects of market volatilities on Health Biotchnology and Cullen Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Biotchnology with a short position of Cullen Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Biotchnology and Cullen Emerging.

Diversification Opportunities for Health Biotchnology and Cullen Emerging

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Health and Cullen is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Health Biotchnology Portfolio and Cullen Emerging Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullen Emerging Markets and Health Biotchnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Biotchnology Portfolio are associated (or correlated) with Cullen Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullen Emerging Markets has no effect on the direction of Health Biotchnology i.e., Health Biotchnology and Cullen Emerging go up and down completely randomly.

Pair Corralation between Health Biotchnology and Cullen Emerging

Assuming the 90 days horizon Health Biotchnology Portfolio is expected to under-perform the Cullen Emerging. In addition to that, Health Biotchnology is 1.58 times more volatile than Cullen Emerging Markets. It trades about -0.4 of its total potential returns per unit of risk. Cullen Emerging Markets is currently generating about 0.0 per unit of volatility. If you would invest  1,296  in Cullen Emerging Markets on September 12, 2024 and sell it today you would lose (1.00) from holding Cullen Emerging Markets or give up 0.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Health Biotchnology Portfolio  vs.  Cullen Emerging Markets

 Performance 
       Timeline  
Health Biotchnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Health Biotchnology Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Cullen Emerging Markets 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cullen Emerging Markets are ranked lower than 8 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical and fundamental indicators, Cullen Emerging is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Health Biotchnology and Cullen Emerging Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Health Biotchnology and Cullen Emerging

The main advantage of trading using opposite Health Biotchnology and Cullen Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Biotchnology position performs unexpectedly, Cullen Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullen Emerging will offset losses from the drop in Cullen Emerging's long position.
The idea behind Health Biotchnology Portfolio and Cullen Emerging Markets pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes